Gene · 6197
Papers2,253
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,253
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptional and chromatin profiling of human blood innate lymphoid cell subsets sheds light on HIV-1 pathogenesis. | EMBO J | 2023 | 37382276 | PubTator, text mining | PubMed |
| Elucidating Fibroblast Growth Factor-Induced Kinome Dynamics Using Targeted Mass Spectrometry and Dynamic Modeling. | Mol Cell Proteomics | 2023 | 37328066 | PubTator, text mining | PubMed |
| An update on the discovery and development of reversible covalent inhibitors. | Med Chem Res | 2023 | 37305209 | PubTator, text mining | PubMed |
| Bone repair and key signalling pathways for cell-based bone regenerative therapy: A review. | J Taibah Univ Med Sci | 2023 | 37305024 | PubTator, text mining | PubMed |
| Myricetin: A Significant Emphasis on Its Anticancer Potential via the Modulation of Inflammation and Signal Transduction Pathways. | Int J Mol Sci | 2023 | 37298616 | PubTator, text mining | PubMed |
| A Study Based on Network Pharmacology Decoding the Multi-Target Mechanism of Duhuo Jisheng Decoction for the Treatment of Intervertebral Disc Degeneration. | Comput Intell Neurosci | 2023 | 37288170 | PubTator, text mining | PubMed |
| A short peptide LINC00665_18aa encoded by lncRNA LINC00665 suppresses the proliferation and migration of osteosarcoma cells through the regulation of the CREB1/RPS6KA3 interaction. | PLoS One | 2023 | 37285335 | PubTator, text mining | PubMed |
| MicroRNA-188-5p inhibits hepatocellular carcinoma proliferation and migration by targeting forkhead box N2. | BMC Cancer | 2023 | 37277714 | PubTator, text mining | PubMed |
| Mechanistic insights into heat shock protein 27, a potential therapeutic target for cardiovascular diseases. | Front Cardiovasc Med | 2023 | 37252119 | PubTator, text mining | PubMed |
| Hepatitis B Virus X Protein Modulates p90 Ribosomal S6 Kinase 2 by ERK to Promote Growth of Hepatoma Cells. | Viruses | 2023 | 37243268 | PubTator, text mining | PubMed |
| Virtual Screening-Based Study of Novel Anti-Cancer Drugs Targeting G-Quadruplex. | Pharmaceutics | 2023 | 37242656 | PubTator, text mining | PubMed |
| Asymmetric Dimethylation of Ribosomal S6 Kinase 2 Regulates Its Cellular Localisation and Pro-Survival Function. | Int J Mol Sci | 2023 | 37240151 | PubTator, text mining | PubMed |
| Complexity of Sex Differences and Their Impact on Alzheimer's Disease. | Biomedicines | 2023 | 37238932 | PubTator, text mining | PubMed |
| AI-Assisted chemical probe discovery for the understudied Calcium-Calmodulin Dependent Kinase, PNCK. | PLoS Comput Biol | 2023 | 37235579 | PubTator, text mining | PubMed |
| Characterization of BoHV-4 ORF45. | Front Microbiol | 2023 | 37234529 | PubTator, text mining | PubMed |
| Different disease inoculations cause common responses of the host immune system and prokaryotic component of the microbiome in Acropora palmata. | PLoS One | 2023 | 37228141 | PubTator, text mining | PubMed |
| Single-cell atlas of the human neonatal small intestine affected by necrotizing enterocolitis. | PLoS Biol | 2023 | 37205711 | PubTator, text mining | PubMed |
| RSK2 inactivation cooperates with AXIN1 inactivation or β-catenin activation to promote hepatocarcinogenesis. | J Hepatol | 2023 | 37201672 | PubTator, text mining | PubMed |
| The CDK4/6 Inhibitor Palbociclib Inhibits Estrogen-Positive and Triple Negative Breast Cancer Bone Metastasis In Vivo. | Cancers (Basel) | 2023 | 37190140 | PubTator, text mining | PubMed |
| Evaluation of Pathogenicity and Structural Alterations for the Mutations Identified in the Conserved Region of the C-Terminal Kinase Domain of Human-Ribosomal S6 Kinase 1. | ACS Omega | 2023 | 37179615 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6197/papers?page=8